Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "vector" return 23 results.
Ceva launches new Vectormune ® website >
Website provides educational resources for poultry professionals, as well as comprehensive information about their vector vaccines range.
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Paris, May 29th 2013 1- Ceva, a socially responsible company committed to the well-being of the planet Ceva Santé Animale is a multi-national French based animal health company that counts over 3000 e...
New Technology Vaccine Symposium - Miami >
Ceva shares global field experiences through New Technology Vaccine Symposium held in the US. Innovation in the hatchery will drive productivity gains
Ceva vector vaccine symposium now available as a web-seminar >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online.
Ceva presents a complete range of vector vaccines at IPE 2013 >
Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
The Perfect Pair is now available >
A great innovation in the protection against Newcastle and Gumboro Diseases
Ceva develops Vectormune© HVT AIV vaccine to combat Avian Influenza >
USDA approval announced at 8th International Symposium on Avian Influenza
Ceva sponsors 8th International Symposium on Avian Influenza >
Innovation in poultry vaccines and solutions reaches beyond animal health
New commercial licenses for viral vaccine production >
Ceva takes commercial license for ProBioGen’s AGE1.CR® Cell Line for viral vaccine production